License system for toll manufacturing medicines triggers debate

The government has approved the license of locally produced drugs by toll manufacturing, when an applicant without GMP facilities intends to make an application of new drugs which have not been available in Korea.

The Korea Food and Drug Administration said the system may ensure the distribution of medicines with better quality, but critics say this will intensify more cut-throat competition...